Cover Image

A 5‐marker immunohistochemical panel of CK17 , MEP1A , PAX8 , SMAD4 , and CDX2 to distinguish ovarian mucinous carcinoma from metastatic pancreatic ductal adenocarcinoma

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Astrid De Boeck, Eun Young Kang, Nicola S Meagher, Kylie L Gorringe, Cheng Han Lee, Parham Minoo, Martin Köbel
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Histopathology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Editorial: Infiltrative pattern of invasion is independently associated with shorter survival and desmoplastic stroma markers FAP and THBS2 in mucinous ovarian carcinoma
by: Carlos Parra‐Herran, et al.
Published: (2024)

Pulmonary immunohistochemical markers may be positive in gastric adenocarcinomas associated with autoimmune metaplastic atrophic gastritis
by: Trevor Toussieng, et al.
Published: (2025)

Molecular and immunohistochemical characterization of ERBB2 activating mutations in low‐grade serous ovarian carcinoma
by: Alexander J Neil, et al.
Published: (2025)

Evaluation of fine‐needle core biopsy specimens for pancreatic ductal adenocarcinoma: Diagnostic utility and helpful histological features
by: Raul S Gonzalez, et al.
Published: (2024)

Identifying mesonephric‐like adenocarcinoma of the endometrium by combining SOX17 and PAX8 immunohistochemistry
by: Maryam Tahir, et al.
Published: (2024)

Molecular pathology of phyllodes tumours of the breast—much more than MED12
by: Jia‐Min B Pang, et al.
Published: (2026)

Clinicopathologic, immunohistochemical and genomic characterization of urothelial carcinoma with myxoid and chordoid features
by: Ting Zhao, et al.
Published: (2025)

Deep‐learning model to improve histological grading and predict upstaging of atypical ductal hyperplasia / ductal carcinoma in situ on breast biopsy
by: Chung‐Yen Huang, et al.
Published: (2024)

Anal squamous cell carcinoma with mucinous microcysts represents anal gland duct differentiation
by: Newton ACS Wong, et al.
Published: (2025)

Diagnostic potential of a novel immunohistochemical marker, GFPT2 , in differentiating mesothelioma from its morphological mimics
by: Jia Wei, et al.
Published: (2025)

Morphological, immunohistochemical and molecular analysis of follicular dendritic cell sarcomas: L1CAM as a new diagnostic marker
by: Selina Schelbert, et al.
Published: (2025)

Primary gallbladder carcinomas showing pancreatic acinar features in the absence of a pancreatic primary
by: Osman Yilmaz, et al.
Published: (2026)

Two similar but distinct types of breast acinar cell carcinoma: evidence from histological, immunohistochemical and molecular features
by: Mingfang Sun, et al.
Published: (2025)

Primary cutaneous sarcomatoid squamous cell carcinoma: a comprehensive clinicopathological and immunohistochemical study focusing on diagnostic pitfalls
by: Jose A Plaza, et al.
Published: (2025)

Shared immunohistochemical and genomic features of the low‐ and high‐grade components of a cutaneous secretory carcinoma with epidermotrophism and lymph node involvement
by: Zlatko Marusic, et al.
Published: (2024)

Tumour‐infiltrating lymphocytes, tertiary lymphoid structures and myxoid stroma predict upstaging of ductal carcinoma in situ in breast biopsies
by: Chung‐Yen Huang, et al.
Published: (2025)

Folate receptor alpha ( FRα / FOLR1 ) and HER2 immunohistochemical staining in high‐grade endometrial carcinoma with aberrant p53 expression
by: Austin McHenry, et al.
Published: (2025)

Mapping the cited evidence of ductal carcinoma in situ from the 5th edition of the World Health Organisation classification of tumours of the breast
by: Clarissa Jing Wen Wong, et al.
Published: (2024)

Merlin‐deficient renal cell carcinoma often exhibits high‐grade cytology, admixed architectural patterns, sclerotic and mucinous stroma, inflammatory infiltrates and calcifications
by: Yang Liu, et al.
Published: (2025)

Correlation between P53 immunohistochemical staining and TP53 molecular testing in endometrial carcinomas: a detailed assessment of discrepant cases with implications for patient management
by: Jesús Machuca‐Aguado, et al.
Published: (2025)

PAX8 ‐positive conventional urothelial carcinomas of the urinary bladder and their distinct molecular profiles – A clinicopathologic study of 101 consecutive cases with next‐generation sequencing in 20 cases
by: Sarah Mae Lammert, et al.
Published: (2026)

Molecular classification of metastatic and recurrent endometrial endometrioid carcinoma: prognostic relevance among low‐ and high‐stage tumours
by: Austin McHenry, et al.
Published: (2024)

Quantitative comparison of immunohistochemical HER2‐low detection in an interlaboratory study
by: Maaike Anna Hempenius, et al.
Published: (2024)

Calcification and tumour‐infiltrating lymphocytes predict upgrade of human epidermal growth factor 2 ( HER2) ‐negative ductal carcinoma in situ diagnosed on core needle biopsy
by: Monalyn Marabi, et al.
Published: (2026)

GATA3 positive spindle cell neoplasm involving the liver diagnosed as metastatic sarcomatoid chromophobe renal cell carcinoma at autopsy
by: Rangsinee Nusapan, et al.
Published: (2025)

Extra‐appendiceal low‐grade mucinous neoplasm‐like lesions: clinicopathologic and molecular characteristics
by: Soo Hyun Lee, et al.
Published: (2026)

Genetic and immunohistochemical studies identify recurrent ACTB mutations and PTEN alterations in tubular adenomas of the breast
by: Hnin Ingyin, et al.
Published: (2025)

Subareolar sclerosing ductal hyperplasia shows PI3K pathway alterations
by: Baris Boyraz, et al.
Published: (2025)

FOXA1 is a highly sensitive diagnostic marker for prostate cancer including small cell carcinoma of the prostate
by: Jianping Zhao, et al.
Published: (2026)

Eosinophilic vacuolated tumour has metastatic potential
by: Benjamin L Coiner, et al.
Published: (2025)

E‐cadherin staining in the diagnosis of lobular versus ductal neoplasms of the breast: the emperor has no clothes
by: Seyed R Taha, et al.
Published: (2024)

Male breast atypical ductal hyperplasia (ADH): clinicopathological insights from a rare cohort
by: Reham Al‐Refai, et al.
Published: (2025)

TERT promoter–mutated thyroid carcinomas: prognostic and histologic insights according to the WHO 2022 classification
by: Seung Eun Lee, et al.
Published: (2026)

Acellular mucin pools and neutrophil‐to‐lymphocyte ratio: unveiling hidden aggressiveness in pathological complete response after chemoradiotherapy for rectal cancer
by: Zhenyu Xu, et al.
Published: (2025)

Genomic analysis of primary epithelial neoplasms of the seminal vesicle identifies a subset of mucinous cystic tumours driven by KRAS mutations
by: Katrina Collins, et al.
Published: (2024)

Dynamic nature of hepatic differentiation in lung adenocarcinoma
by: Chihiro Takemura, et al.
Published: (2025)

Molecular characterization of clear cell adenocarcinoma of the urinary bladder
by: Shilpy Jha, et al.
Published: (2026)

BRCA1‐associated‐protein‐1 inactivated melanocytic tumours: characterisation of the clinicopathological spectrum and immunohistochemical expression pattern of preferentially expressed antigen in melanoma
by: Yitong Xu, et al.
Published: (2024)

Diagnosis of verruciform acanthotic vulvar intra‐epithelial neoplasia (vaVIN) using CK17, SOX2 and GATA3 immunohistochemistry
by: Eleanor Cook, et al.
Published: (2024)

Ki‐67 distribution, α‐methylacyl‐CoA racemase (AMACR) expression and mucin phenotypes are associated with non‐polypoid growth in ulcerative colitis‐associated neoplasia
by: Soh Okano, et al.
Published: (2024)